Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1

Glycobiology

Volumn 11, Issue 1, 2001, Pages 11-19

  Polzer, Svenja ^a   Dittmar, Matthias T ^b   Schmitz, Herbert ^a   Meyer, Bernd ^c   Müller, Harm ^a   Kräusslich, Hans Georg ^b   Schreiber, Michael ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Coreceptor; Glycosylation; HIV 1; Infectivity; V3 loop

Indexed keywords

CARBOHYDRATE; CHEMOKINE RECEPTOR CXCR4; GLYCAN; GLYCOPROTEIN GP 120; LIGAND; OLIGOSACCHARIDE; STROMAL CELL DERIVED FACTOR 1; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS RESISTANCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0035098352     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/11.1.11     Document Type: Article

References (51)

1. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
2. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
3. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization
4. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4 and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation
5. A new classification for HIV-1
6. High-efficiency transformation of mammalian cells by plasmid DNA
7. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
8. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
9. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
10. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: Induction and enhancement by soluble CD4
11. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
12. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
13. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
14. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution
15. Identification of a major co-receptor for primary isolates of HIV-1
16. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors
17. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
18. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus
19. AIDS and glycosylation
20. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
21. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1
22. The role of viral diversity in HIV pathogenesis
23. Solution structure of the V3 loop of a Thailand HIV isolate
24. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
25. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype
26. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus
27. Oligosaccaride-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition
28. Quantification of CD4, CCR5 and CXCR4 levels on lymphocyte subsets, dendritic cells and differentially conditioned monocyte-derived macrophages
29. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
30. Host-cell-specific glycosylation of HIV-2 envelope glycoprotein
31. The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant
32. Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells. J
33. V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability
34. Dissociation of gp120 from HIV-1 virions induced by soluble CD4
35. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
36. Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4 but not CCR-5 dependent fusion
37. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety
38. Glycosylation of two recombinant human uterine tissue plasminogen activators variants carrying an additional N-glycosylation site in the epidermal-groth-factor-like domain
39. A role for carbohydrates in immune evasion in AIDS
40. Dynamics of syncytium-inducing and non-syncytium-inducing type 1 human immunodeficiency viruses during primary infection
41. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120
42. Pathogenicity and diversity of HIV and implications for clinical management: A review
43. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection
44. Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer
45. Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1
46. Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum
47. Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDS
48. A new force-field program for the calculation of glycopeptides and its application to a heptacosapeptide-decasaccharide of immunoglobulin G1. Importance of 1-6-glycosidic linkages in carbohydrate peptide interactions
49. The antigenic structure of the HIV gp120 envelope glycoprotein
50. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1